Table 2 Distribution of indication for IOL in particular groups.
From: Misoprostol vs dinoprostone vaginal insert in labour induction: comparison of obstetrical outcome
Indication for induction of labour | MVI (n = 367) | DVI (n = 114) | Total (n = 481) | p |
|---|---|---|---|---|
Post-term pregnancy [n,%] | 203 (55.3%) | 66 (57.9%) | 269 (56%) | 0.62 |
Gestational diabetes [n,%] | 55 (14.9%) | 12 (10.5%) | 67 (13.9%) | 0.22 |
Hypertensive disorders in pregnancy [n,%] | 47 (12.8%) | 16 (14.03%) | 63 (13%) | 0.73 |
Fetal hypotrophy (FGR/SGA) [n,%] | 26 (7%) | 6 (5%) | 32 (6.4%) | 0.49 |
Other indications [n,%] | 36 (9.8%) | 14 (12.2%) | 50 (10.3%) | 0.45 |
